2008ChemMedChemRequires access

Cover Picture: A Composite Model for hERG Blockade (ChemMedChem 2/2008)

Christian Krämer, Bernd Beck, Jan M. Kriegl, Timothy Clark

Open publisher page 0 citations

Abstract

The cover picture shows a schematic representation of the hERG-encoded potassium channel together with one pharmacophore for potent hERG inhibitors, the MEP surface of cisapride, a potent hERG inhibitor, and a plot of measured versus predicted hERG IC50 values. Blockade of the hERG channel leads to a prolongation of the QT interval, which might lead to torsades des pointes, an uncontrolled excitation of heartbeats. On the cover picture, an ECG plot of normal heartbeats (middle left side) and an ECG plot of torsades des pointes (middle right side) is shown in white. Torsades des pointes might lead to lethal ventricular fibrillation. Therefore the inhibition of hERG is one of the major toxicological endpoints addressed in preclinical drug development. The combination of different hERG pharmacophores, derived from highly potent structurally diverse inhibitors together with specific QSAR models, offers a novel approach to predict hERG blockade. For details, see the Full Paper by B. Beck, T. Clark, et al. on p. 254 ff.

About this research paper

What this paper is about

The cover picture shows a schematic representation of the hERG-encoded potassium channel together with one pharmacophore for potent hERG inhibitors, the MEP surface of cisapride, a potent hERG inhibitor, and a plot of measured versus predicted hERG IC50 values. Blockade of the hERG channel leads to a prolongation of the QT interval, which might lead to torsades des pointes, an uncontrolled excitation of heartbeats. On the cover picture, an ECG plot of normal heartbeats (middle left side) and an ECG plot of torsades des pointes (middle right side) is shown in white. Torsades des pointes might lead to lethal ventricular fibrillation. Therefore the inhibition of hERG is one of the major toxicological endpoints addressed in preclinical drug development. The combination of different hERG pharmacophores, derived from highly potent structurally diverse inhibitors together with specific QSAR models, offers a novel approach to predict hERG blockade. For details, see the Full Paper by B. Beck, T. Clark, et al. on p. 254 ff.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The cover picture shows a schematic representation of the hERG-encoded potassium channel together with one pharmacophore for potent hERG inhibitors, the MEP surface of cisapride, a potent hERG inhibitor, and a plot of measured versus predicted hERG IC50 values. Blockade of the hERG channel leads to a prolongation of the QT interval, which might lead to torsades des pointes, an uncontrolled excitation of heartbeats. On the cover picture, an ECG plot of normal heartbeats (middle left side) and an ECG plot of torsades des pointes (middle right side) is shown in white. Torsades des pointes might lead to lethal ventricular fibrillation. Therefore the inhibition of hERG is one of the major toxicological endpoints addressed in preclinical drug development. The combination of different hERG pharmacophores, derived from highly potent structurally diverse inhibitors together with specific QSAR models, offers a novel approach to predict hERG blockade. For details, see the Full Paper by B. Beck, T. Clark, et al. on p. 254 ff.

Key concepts: hERG, Torsades de pointes, Pharmacophore, QT interval, Blockade, Chemistry, Pharmacology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Cover Picture: A Composite Model for hERG Blockade (ChemMedChem 2/2008) — Research Paper | ScholarLens